PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 10, 2026Case Reports in Dermatology0 citationsOpen Access

Baboon Syndrome Triggered by Diclofenac Potassium: A Case Report of Symmetrical Drug-Related Intertriginous and Flexural Exanthema

View Full Paper
AAAbdalwahab AlKanderiAMAlsadat MosbehAAAbeer A. Albazali

Key Points

  • To report a case of baboon syndrome (SDRIFE) triggered by diclofenac potassium in a 53-year-old male.
  • Descriptive case report of a 53-year-old gentleman with baboon syndrome after using diclofenac potassium for knee pain.
  • Symmetrical erythema observed in multiple flexural areas with no systemic symptoms.
  • Management included cessation of diclofenac, followed by topical corticosteroids and oral antihistamines.
  • Symmetrical erythema resolved after one week post cessation of diclofenac potassium.
  • Distinct erythema distribution matched known patterns of SDRIFE.
  • No systemic symptoms such as fever were present.

Abstract

Background: Baboon Syndrome, also known as symmetrical drug-related intertriginous and flexural exanthema (SDRIFE), is a rare reaction characterised by distinct, bilateral erythema in the flexural and intertriginous regions, occurring without further symptoms. Case report: We present a 53-year-old gentleman who, three days after commencing diclofenac potassium for knee pain, exhibited symmetrical, well-defined erythema affecting the neck, axillae, cubital and popliteal fossae, forearms, inguinal folds, thighs, legs, and feet. He displayed no systemic symptoms or fever. The time and distinctive distribution of SDRIFE induced by diclofenac potassium were congruent. Management and Outcome: Following the cessation of diclofenac potassium, the patient received topical corticosteroids and oral antihistamines. The symptoms resolved after one week. In conclusion, this case highlights the necessity for physicians to identify this presentation for prompt diagnosis and care, and also indicates diclofenac potassium as a possible cause of SDRIFE. Keywords: Diclofenac potassium, Baboon Syndrome, SDRIFE, Flexural Erythema, Cutaneous Drug Eruption

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

AlKanderi et al. (2026) studied this question.

synapsesocial.com/papers/6a0020cec8f74e3340f9b977https://doi.org/10.1159/000552458
Ask AI
Helpful
Bookmark
Share
View Full Paper